HEA is a consortium of independent health economics experts who specialize in helping the world’s leading biopharmaceutical, medical device, and diagnostic companies achieve market access for their new therapies by integrating health economics research into their product’s commercialization strategy.

Michael Mafilios – Founder and Principal Consultant

Michael Mafilios is the founder of Health Economics Associates LLC and lead consultant for all HEA research projects. He is a health economist and medical writer with 20 years of experience in health economics research and consulting. Michael specializes in designing health economic evaluations (including cost-effectiveness models, decision analysis models, and budget impact models), preparing global value dossiers and local reimbursement dossiers (including AMCP dossiers), performing literature reviews, customizing HTA submissions (CADTH and NICE), and developing value messages to communicate the clinical, economic, and humanistic story of a new therapy to healthcare payers and providers. Michael has co-authored several papers and abstracts in leading medical journals on the costs and outcomes of medical technology and has conducted research in the areas of infectious disease, oncology, obesity, nephrology, neurology, ophthalmology, orthopedics, pain management, and urology.

Prior to founding HEA, Michael worked at Covance Health Economics and Outcomes Services as a senior health economics research consultant.  He received a B.A. from Georgetown University and also completed the Harvard School of Public Health’s Continuing Education Program in Cost-Effectiveness Analysis for Medical Technologies and Pharmaceuticals.